Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Ligand Completes Acquisition of XOMA Royalty, Creating a Portfolio of More than 200 Biopharmaceutical Royalty Assets
Wednesday, July 15, 2026Ligand Pharmaceuticals Incorporated Nasdaq LGND today announced it has completed its acquisition of XOMA Royalty Corporation XOMA Royalty a biotechnology royalty aggregator for per
Insilico Medicine and Bora Pharmaceuticals Announce Strategic Alliance for AI-Driven Drug Discovery and Development
Wednesday, July 15, 2026Insilico Medicine Insilico HKEX a clinicalstage generative artificial intelligence AIdriven drug discovery company today announced a multitarget strategic alliance with Bora Pharmaceuticals Co Ltd
Boehringer Ingelheim reports first-half 2026 sales growth, driven by JARDIANCE® and new product launches in the U.S.
Wednesday, July 15, 2026Boehringer Ingelheim reported continued sales growth in the first half of driven by strong growth in the US due to increased demand for JARDIANCE empagliflozin and successful new launches
AstraZeneca enters exclusive global license agreement for novel oral EGFR inhibitor Zegfrovy for lung cancer with Dizal Pharmaceutical
Tuesday, July 14, 2026AstraZeneca has entered into an exclusive license agreement with Dizal Pharmaceutical Co Ltd for Zegfrovy sunvozertinib a novel oral irreversible epidermal growth factor receptor EGFR inhibitor for patients
Servier completes the acquisition of Edgewise Therapeutics' Muscular Dystrophy Business
Tuesday, July 14, 2026Servier an independent international pharmaceutical group governed by a foundation today announced that it has completed the acquisition of the muscular dystrophy business of Edgewise Therapeutics Inc
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma
Tuesday, July 14, 2026Bristol Myers Squibb NYSE BMY today announced that the US Food and Drug Administration FDA has accepted a New Drug Application NDA for mezigdomide in combination with carfilzomib
Santhera Expands Biomedica Agreement to Extend AGAMREE® (Vamorolone) Distribution Across Central Asia and the Caucasus
Monday, July 13, 2026Santhera Pharmaceuticals today announces an expansion of its exclusive distribution agreement with Biomedica for AGAMREE vamorolone extending the partnership to include Georgia Kazakhstan Belarus
Novogene Europe Launches Untargeted Metabolomics Service at Cambridge Omics Centre
Monday, July 13, 2026Novogene Europe a multiomics research services partner today announced that it has strengthened its position as a multiomics partner with the launch of its Untargeted Metabolomics Service through its Cambridge Omics Centre
Omnix Medical Launches New Horizon Europe PEPTAMR Infectious Disease Consortium
Monday, July 13, 2026Omnix Medical a biopharmaceutical company developing nextgeneration antiinfectives for the treatment of lifethreatening infections today announced the launch of the PEPTAMR consortium bringing together leading European clinical
TolerogenixX Has Received EMA Orphan Drug Designation for MIC-Lx, Strengthening its Regulatory Pathway in Kidney Transplantation
Monday, July 13, 2026TolerogenixX a German clinicalstage biopharmaceutical company developing personalized cell therapies inducing antigenspecific immune tolerance today announced that the European Commission
